PK, Safety & Tolerability of CyCol® Versus Sandimmune® in Healthy Subjects
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
The aim of this Phase I, single centre, multi stage study is to evaluate the safety,
tolerability, pharmacokinetics and relative colonic mucosal concentrations of cyclosporine
capsules (CyCol®) compared to intravenous cyclosporine in healthy male volunteers.